To test if anti-VISTA affects direct killing of tumor cells by T cells, we evaluated cytotoxicity of CD8 + T cells on the JH716-OVA cell line in the presence of VISTA or PSGL-1 neutralizing antibodies (Fig. 6H). The gene discussed is VSIR; the disease is neoplasm.